VisExcell
2015
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
$600K
LATEST DEAL AMOUNT
1
INVESTORS
Description
Developer of a breast cancer risk judgement platform designed to reduce the risk of breast cancer. The company's breast cancer risk judgement platform uses machine learning and computer vision to deliver risk models and automated physician annotation through the use of mammograms, enabling women to assess the risk of breast cancer.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Software
Other Healthcare Technology Systems
Primary Office
- 2211 Bryn Mawr Avenue
- Ardmore, PA 19003
- United States
+1 (215) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore VisExcell’s full profile, request a free trial.
VisExcell Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 04-Mar-2016 | $600K | 00000 | Completed | Startup | |
| 1. Accelerator/Incubator | 26-Oct-2015 | 0000 | 0000 | 00000 | Completed | Startup |
VisExcell Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| DreamIt Ventures | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |
VisExcell Executive Team (3)
VisExcell Board Members (3)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Elizabeth Haynes | VisExcell | Board Member & Executive Officer | 000 0000 | |
| Mahender Nathan | VisExcell | Co-Founder, Board Member & President | 000 0000 | |
| Steve Moore | VisExcell | Co-Founder, Board Member & Vice President of Technology Research & Development | 000 0000 |